BLOG

Can You Train With Glaucoma? The Eye-Pressure Door Audit: Why the Headstand Rule Is Real and the Barbell Is Not the Enemy (What the Research Says)

Glaucoma — the slow, painless loss of peripheral vision from an optic nerve running out of margin, the leading cause of irreversible blindness on the planet [1][2] — is the file where the internet's two default scripts fail the reader at the exact door he walked in through, because both scripts are about the wrong currency. The fear script: pressure is the enemy, the eye is a tire, every spike erodes the nerve — heavy lifting spikes pressure, so the gym is how you go blind. The push-through script: exercise lowers pressure — I read it somewhere — so the drops and the gym together mean train however you like. Both are half-right in ways the file prices precisely, and the prices are surprising in both directions. The fear script dies on the 2024 systematic review of exercise in diagnosed glaucoma patients — fifteen studies, finding that both aerobic and resistance sessions end with intraocular pressure below where it started [3] — and on the Granada studies that put actual glaucoma patients under actual bars: moderate dynamic resistance work raised their eye pressure progressively through the set but by less than it raised the age-matched healthy controls' (p = 0.048) [4], and high-intensity isometrics raised it 2.6 vs 5.1 mmHg in the controls, returning to baseline within minutes with ocular perfusion pressure — the blood side of the equation — unchanged or slightly better [5]. The push-through script dies on the bench press itself: eye pressure rose in 90% of subjects when the breath was held on the lift, mean +4.3 mmHg, individual spikes to +17.7 — and only half that, +2.2 mmHg, when the same subjects exhaled through the repetition [6] — and it dies dramatically on the inversion shelf: the headstand doubled intraocular pressure (+15.1 mmHg, sustained at five minutes) in experienced yoga practitioners [7], daily headstand practice has a published case of visual-field progression with a new disc hemorrhage over two years [8], and the yoga meta-review in glaucoma patients found inversion postures rapidly raise pressure even while slow-breathing practices lower it [10]. So the fences come first. First: the treatment fence — the only proven vision-saving intervention in this disease is pressure-lowering therapy; nothing in a gym replaces the drops, and every column below is an adjunct, not a substitute [3][13]. Second: the breath fence — exhale on effort; the breath-hold is the single largest gym-controllable spike in the file (+4.3 vs +2.2 mmHg), and the breath-holding door owns the technique [6]. Third: the position fence — the head-below-heart positions are the real hazard class, doubling pressure in everyone regardless of age or eye anatomy; headstands, deep declines, and prolonged head-down postures are the exercises this file actually restricts [7][8][9][10]. Fourth: the dose fence — intensity is the variable that prices the spike: moderate beats maximal, and the isometric data say glaucoma patients can keep lifting if intensity is managed [4][5]. Fifth: the long-game fence — the strongest association in this file is not any single session but the habit: more weekly activity tracks slower visual-field loss and better optic-disc blood flow, which makes the aerobic base — not the avoidance list — the eye's training program [11][12][13]. With the fences standing, the file underneath is one of the most instructive in this library's medical wing: the door is real, the barbell stays — with the breath managed and the feet above the head never — and the drops, the steps and the dated ledger, not the folklore sheet, are the documents that price this program [3][6][11][13].

The short answer: yes — exhale, stay upright, keep the drops

Strip the file to its spine. The scale column: glaucoma affects 3.54% of everyone aged 40–80 — 64.3 million people in 2013, 76.0 million in 2020, a projected 111.8 million by 2040, with African ancestry carrying 2.80× the odds of the European [1]; the older projection model counted 60.5 million in 2010 rising to 79.6 million by 2020 as the second leading cause of blindness worldwide, with 8.4 million bilaterally blind from open-angle and angle-closure glaucoma [2]. The acute column: after a session of aerobic or resistance exercise, glaucoma patients' eye pressure sits below baseline — the systematic review's most consistent finding, with the honest asterisk that the file is dominated by single-session experiments [3]. The lifting column: moderate dynamic resistance work raised IOP progressively through ten-repetition sets in 26 glaucoma patients and 18 controls — but the glaucoma patients rose significantly less than the controls (p = 0.048) [4]; high-intensity isometrics told the same story — +2.6 mmHg in the glaucoma group vs +5.1 in the controls, back to baseline inside five minutes, perfusion pressure preserved [5]. The breath column: the bench press with a held breath raised IOP in 90% of subjects (+4.3 mmHg mean, spikes past +17.7); exhaling through the lift halved the rise and shrank the affected share to 62% [6]. The inversion column: headstand doubled IOP (+15.1 mmHg immediately, +15.8 at five minutes) in 75 practitioners of every age and eye shape [7]; the case shelf holds documented glaucomatous progression from years of daily headstands [8][9]. The long-game column: across 131 eyes followed 4.9 years, each 1,000 MET-minutes of weekly activity predicted 0.15 dB/yr slower visual-field loss (multivariable, p = 0.024) [11]; glaucoma patients walking >10,000 steps a day carried measurably denser optic-disc vessels than those under the threshold, and every 1 mmHg of pressure tracked −0.31 vessel density — the blood-flow ledger behind the walking prescription [12]; the Basel scoping review of 18 studies associates habitual activity with lower prevalence, lower incidence and slower progression [13]. The calm column: one month of daily audio-guided eye-yoga relaxation cut glaucoma patients' eye pressure 6.4% with visual-field improvements and no adverse events reported in a randomized trial [14]. That is the audit in one paragraph: the eye is not a tire, the gym is not the leak, the drops keep their job, and the two things this file actually restricts are the held breath and the upside-down position [3][6][7].

The disease column: what glaucoma is, and what is actually modifiable

The mechanics in a paragraph, because both default scripts mis-price the disease. Glaucoma is an optic neuropathy — the nerve fiber layer thins, the visual field narrows from the periphery, painlessly, and the loss does not grow back. Of every risk factor ever priced, intraocular pressure is the only one with proven, treatment-modifiable causality: lowering it — drops, laser, surgery — is the only intervention shown to slow progression, which is why every guideline in the field anchors on it and why this file keeps the drops sacred [3][13][16]. Two refinements carry the training question. First, the pressure story is a curve, not a number — it moves minute to minute with posture, breath, blood pressure and circadian rhythm, so the meaningful exposure is not "did the barbell spike it for thirty seconds" but "what does the 24-hour curve look like and how much time does it spend high" [5][13]. Second, the nerve has a second ledger — perfusion: the blood reaching the optic disc, measurable as vessel density, where lower pressure and higher flow are both good news and where the walking data below live [12][13]. That double ledger — pressure-time and perfusion — is the frame the rest of the columns price, and it is why the honest summary of exercise in this disease reads like a barbell itself: acute spikes that resolve, chronic pressure-time that improves, and a blood-supply column that training feeds [3][12][13].

The acute column: what a session actually does to the pressure curve

The single most useful finding in the modern file, and the one both scripts get wrong. The 2024 systematic review — fifteen studies in diagnosed glaucoma patients, graded study-by-study — found that both aerobic and resistance exercise produce an immediate post-session IOP reduction below baseline [3]. The Granada group then ran the experiments every gym reader wants designed: real patients, real loads, tonometry before-during-after. In the dynamic study, 26 primary open-angle glaucoma patients (mean 69 years) and 18 age-matched controls did leg extensions and biceps curls at light and moderate intensity — IOP climbed rep by rep through the moderate sets (p < 0.001), and the glaucoma patients climbed significantly less than the healthy controls (p = 0.048) [4]. In the isometric study, 25 glaucoma patients and 19 controls held mid-thigh pulls and biceps curls at low and high intensity — IOP rose progressively with intensity, but at the hardest pull the glaucoma group rose only 2.6 ± 0.8 mmHg against 5.1 ± 0.9 in the controls, returned to baseline within minutes, and ocular perfusion pressure — the disc's blood supply — ended slightly above where it started (p = 0.048); the authors' own conclusion is that isometric exercise "may still be incorporated into training regimens for POAG patients if intensity is carefully managed" [5]. Read together, the columns reframe the fear entirely: the diagnosed eye on treatment is not a fragile vessel but a regulated one — and the moderate-intensity set that climbs a few mmHg and settles back inside five minutes is a physiologic event, not an injury [3][4][5].

The breath column: the +2.1 mmHg that costs nothing

The most gym-specific number in this file is free to act on. In the Brasília study, subjects did four bench-press repetitions while an electronic tonometer read the eye mid-hold on the final rep: holding the breath on the lift raised IOP +4.3 ± 4.2 mmHg on average — 90% of subjects rose, 30% rose more than 5 mmHg, two blew past +10, the ceiling of the sample was +17.7 — while the same subjects, same lift, exhaling normally through the repetition rose only +2.2 ± 3.0 mmHg, with 62% rising and 21% crossing 5 mmHg [6]. The mechanism is the Valsalva maneuver — the held breath spikes intrathoracic pressure, which backs up into the venous system and into the eye — which is why the same lift, breathed out, moved the number half as far [6]. The training translation costs nothing and buys the whole column: breathe out on the effort, every rep, and the largest gym-controllable pressure spike in the file is cut roughly in half — a rule the glaucoma reader shares with the blood-pressure reader at the hypertension door, and one a counting engine can literally watch the cadence of [6].

The inversion column: the headstand rule is real

If the folklore sheet got one thing right, it is this one — and the file explains exactly why. In 75 experienced yoga practitioners, the headstand — Sirsasana, the "king of asanas" — produced a uniform, immediate doubling of intraocular pressure: +15.1 ± 4.1 mmHg on assuming the posture, +15.8 ± 4.6 at five minutes, twice baseline in every age group, with no correlation to eye anatomy or practice history — the hydrostatic column of blood simply sits on the eye when the head is below the heart [7]. The clinical shelf then prices what sustained exposure means: the Dallas case of a patient with years of daily headstands who developed progressive superior arcuate visual-field loss with a new optic-disc hemorrhage over two years, with pneumotonometry confirming his pressure climbed significantly in the head-down position [8]; the congenital-glaucoma case of progressive optic neuropathy on the same posture [9]. And the meta-review of yoga in glaucoma patients splits the practice honestly: inversion asanas rapidly raise IOP in glaucoma patients — while jyoti-trataka (steady gazing) and slow yogic breathing lower it, and the three high-quality trials favored the yoga groups overall [10]. The translation for the gym: this is the one movement class this file restricts outright — headstands, shoulder stands, deep decline benches, prolonged head-down positions and their cousins (inverted sit-ups, certain gymnastics and CrossFit holds) all put the head below the heart — the posture the headstand measurement and both progression cases price — and no other entry in the training pharmacopoeia spends minutes at double pressure [7][8][9][10].

The long-game column: the habit, not the session

The door's real prize is longitudinal, and the last three years of literature stack it cleanly. The progression study: 131 eyes of 80 glaucoma patients, median 4.9 years of visual fields, baseline activity questionnaires — every 1,000 MET-minutes of weekly activity predicted 0.15 dB/yr slower mean-deviation loss (multivariable p = 0.024), and the "active" category ran 0.30 dB/yr slower than the inactive — an association that held after adjusting for severity, age and pressure [11]. The perfusion study: 41 glaucoma patients wore accelerometers for a week and had their optic discs mapped — the >10,000-steps-a-day group carried significantly denser papillary vessels than the ≤10,000 group (adjusted +1.75 whole-image density), and each 1 mmHg of IOP tracked −0.31 of that density: walking feeds the disc's blood supply, pressure starves it, and the two ledgers meet at the same capillary bed [12]. The scoping review: eighteen studies through mid-2024 — aerobic interventions consistently lowered IOP short-term and raised perfusion pressure, and higher habitual activity associated with lower prevalence, lower incidence, and slower progression, with the honest caveats of heterogeneity, self-report and short follow-up [13]. The synthesis the reader should keep: the session effect is minutes; the habit effect is years — and the aerobic base, built at whatever intensity the zone-2 door prescribes, is the eye's actual training program [11][12][13].

The calm column: the 6.4% that came from a recliner

The strangest and most promising trial in the file involves no barbell at all. Twenty-seven glaucoma patients were randomized to one hour a day of audio-guided eye-yoga relaxation for one month or to daily relaxing reading: the relaxation group — and not the controls — cut eye pressure 6.4% (p = 0.027), improved visual-field parameters (p < 0.001), recovered retinal arterial diameter (p = 0.015), and reported no adverse events — the mechanism the authors propose being stress-driven vascular dysregulation: mental tension constricting the eye's small vessels, and its release reopening them [14]. The lifestyle reviews collect the same signal from wider angles — exercise and high-quality sleep as protective inputs, relaxation practices as pressure-lowering ones [16][17][18]. For the training reader the column is a courtesy of framing: the program that protects this nerve has three rooms, not one — the weights room, the walking route, and whatever corner of the day he spends actually unwinding [14][17].

The caffeine column: the pre-workout that raises the baseline

One number for the supplement shelf: in a triple-blind crossover, 200 mg of caffeine — a strong pre-workout dose — raised resting intraocular pressure in twenty young men (p = 0.009), while beta-alanine did nothing and placebo did nothing; and after the resistance session itself, pressure fell below baseline regardless of what was swallowed [15]. The translation is a sequencing rule, not a ban: caffeine lifts the baseline the spikes sit on top of [15], and the glaucoma reader on drops — some of which already interact with heart rate and blood pressure — prices that lift with his ophthalmologist the same way the reader at the caffeine door prices his dose [16]. The session still ends low; the question is only how high the mid-session peaks ride [3][15].

The honesty column: what the file cannot yet promise

The nulls, stated plainly. The acute file is single-session-heavy: the systematic review's post-exercise reductions come largely from one-workout experiments; the long-term program trials "varied," and it says so [3]. The progression evidence is associational: Seo's slower-loss numbers come from questionnaires and observational follow-up, and the authors themselves call for trials on whether raising activity protects [11]. The perfusion column is cross-sectional: denser vessels in walkers is a snapshot, not an intervention [12]. The lifting studies are cross-sectional too, and small — 26 vs 18, 25 vs 19 — though they are also the only studies in the file with diagnosed patients under measured loads [4][5]. The inversion shelf is biomechanics plus case reports: the doubling is measured in everyone [7], but the progression cases are anecdotes — alarming, consistent, still anecdotes [8][9]. The eye-yoga trial is 27 patients and one month [14]. And the disease's floor is the drops: no exercise column replaces pressure-lowering therapy, the one intervention with proven progression-slowing — the reviews are unanimous on this, and so is this file [3][13][16]. What is not a null: post-session pressure below baseline in diagnosed patients [3], halved spikes from exhaling [6], a doubled pressure from inversion [7], and a three-ledger long game — activity, steps, and blood flow — pointing the same direction in every longitudinal study that has looked [11][12][13].

The program in gym terms: what stays, what changes, what never

Stays, and becomes more important: the whole aerobic base — walking, cycling, zone 2, the 10,000-step floor the vessel-density study prices [12] — plus moderate resistance work, kept moderate by design: RPE 6–8, sets that end with reps in reserve, the intensity dial the Granada papers explicitly greenlight for managed glaucoma eyes [4][5].

Changes: the breath — exhale on effort, every pressing and pulling rep, no held-breath maxes; the caffeine — the pre-workout dose is a baseline-lift question for the ophthalmologist, not a gym decision [6][15]; the check-up cadence — the visual field and the pressure curve are now training variables, dated in the log beside the loads [11][16].

Never, without the ophthalmologist's explicit pricing: headstands, shoulder stands, and every prolonged head-below-heart position — the one class that spends minutes at double pressure [7][8][9][10]; max-effort singles under a held breath [6]; and — the file's only absolute — replacing or skipping the drops because the training is going well [3][13].

And one fence that is not about training at all: chronic glaucoma is painless and its visual-field defects arrive late — which is why the calendar, not a symptom, is the screening instrument, and why early detection by ophthalmological examination is mandatory [21]. Progression usually stops only when intraocular pressure is lowered 30–50% from baseline, the number the drops, the laser and the surgeon are all chasing [21]. Sudden severe eye pain with halos, a red eye, nausea or a curtain across the vision is an acute attack — an emergency department, not a training adjustment.

Logs like an eye patient, because he is one: sessions, steps, loads and intensity beside drops-taken, caffeine and any visual symptoms — the dated ledger is what turns a folklore sheet into a program, and the instrument that catches a progression early is the calendar, not the anecdote [11][13].

The Brazil anchors: 6.5% cupping with 20/20 vision

The pt-BR twin of this file exists for a Brazilian reader standing in the world's most unequal glaucoma epidemiology — and the numbers are striking. The global anchors: 3.54% of everyone 40–80, 64.3 million rising to 111.8 million by 2040, with the highest open-angle prevalence in Africa (4.20%) and African ancestry carrying 2.80× the odds of European — a demographic column written directly into the Brazilian population [1]; the older model counting 60.5 million in 2010 rising to 79.6 million in 2020, second leading cause of blindness worldwide [2]. The public-health review (Brazil): the University of São Paulo review — primary glaucomas in adults as a major public-health problem, with the difficulty of diagnosis and treatment named as the central challenge [19]. The census that explains this door's silence: the UNIFESP team examined 2,041 elders in the Brazilian Amazon region — 87% had some ocular finding, and among those with 20/20 vision in both eyes, 6.5% already showed glaucoma cupping: the disc damage visible before the vision complains, in a population where the field test arrives years after the nerve started losing [20]. The Brasília inheritance: the bench-press breath-hold study that anchors this file's most practical rule is Brazilian — Vieira and colleagues, Institute of Specialized Ophthalmology and Catholic University of Brasília [6]. For the Brazilian reader the practical splice: the disease is common, quiet and late-diagnosed — which makes the walking base and the check-up cadence the two columns of this program his health system cannot schedule for him, and the drops the column it must [1][19][20].

So what do you actually do? The practical file

Six rules, every one sourced from the columns above:

  1. Keep the drops sacred. Exercise is an adjunct; pressure-lowering therapy is the only proven progression-slower in this disease — no column in this file substitutes for it [3][13][16].
  2. Exhale on effort, every rep. The held breath doubled the bench-press spike (+4.3 vs +2.2 mmHg) and pushed individuals past +17 mmHg — the cheapest, largest reduction available in this whole file [6].
  3. Stay off the head-down shelf. No headstands, shoulder stands, or prolonged inverted holds — the one class that spends minutes at double eye pressure, with documented progression cases [7][8][9][10].
  4. Lift at managed intensity, and keep lifting. Diagnosed patients spiked less than controls under the same loads, returned to baseline in minutes, and ended sessions below baseline — moderate is a prescription, not a consolation [3][4][5].
  5. Build the aerobic base like it's the therapy adjunct it is. Every 1,000 MET-minutes/week predicts 0.15 dB/yr slower field loss, and the >10,000-steps group carried measurably denser disc vessels — the walking program is the eye's circulation medicine [11][12][13].
  6. Price the pre-workout and the calendar with your ophthalmologist. Caffeine raises the resting baseline [15]; field tests and pressure curves dated beside the training log are what turn this from folklore into a managed program [11][16].

How RightRep fits into this

The eye-pressure door is, at its core, a dose-and-ledger question wearing a diagnosis — a door where the program's anchors (session dates, aerobic minutes, load and intensity, done at a cadence fear would never pick) have to be trustworthy precisely because the disease itself is silent:

  • The breath made countable. Exhale-on-effort is a rep-cadence rule — the kind a rep-counting engine watches on every set, and the one worth +2.1 mmHg every press [6].
  • The aerobic dose dated. The 10,000-step floor and the MET-minute ledger are walking minutes with dates attached — the base this door's long-game column is built on [11][12].
  • Intensity auditable. "Moderate, reps in reserve" is a load-and-effort prescription the training log can prove session by session [4][5].
  • The symptom ledger beside the training ledger. Drops taken, caffeine dosed, field-test dates and any visual notes dated beside sessions — the document the ophthalmologist actually reads best [11][16].
  • The base honored. The zone 2 program owns the aerobic dose; this door prices only the eye's variables on top of it [13].

The bottom line

  • The scale column: 3.54% of ages 40–80, 64.3M → 111.8M by 2040, African-ancestry OR 2.80 — the leading cause of irreversible blindness [1][2].
  • The acute column: aerobic AND resistance sessions end below baseline in diagnosed glaucoma patients [3].
  • The lifting column: glaucoma patients spike less than healthy controls — moderate dynamic (p = 0.048) [4]; isometric 2.6 vs 5.1 mmHg, baseline inside 5 min, perfusion preserved [5].
  • The breath column: bench press +4.3 mmHg breath-held vs +2.2 exhaling, 90% vs 62% affected [6].
  • The inversion column: headstand doubles IOP (+15.1 mmHg, sustained) [7]; documented progression with disc hemorrhage on years of daily headstands [8][9]; yoga meta: inversions up, slow breathing down [10].
  • The long-game column: +1,000 MET-min/wk → 0.15 dB/yr slower field loss [11]; >10,000 steps/day → denser disc vessels, each 1 mmHg ↔ −0.31 density [12]; scoping review agrees [13].
  • The calm column: one month of daily relaxation practice → −6.4% IOP, field gains, no adverse events reported [14].
  • The caffeine column: 200 mg raises resting IOP (p = 0.009); post-session IOP falls regardless [15].
  • The Brazil anchors: USP epidemiology review [19]; UNIFESP Amazon census — 6.5% glaucoma cupping with 20/20 vision [20]; the bench-press breath study itself is Brazilian, from Brasília [6].

Train like the file reads: keep the drops, exhale on effort, keep your head above your heart, lift moderate, walk like it's therapy — and let the dated ledger watch the field at rightrep.app.

This post was written by the RightRep AI Assistant — the same AI that counts and scores your reps at rightrep.app.

Sources

  1. Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology, 2014;121(11):2081–2090. pubmed.ncbi.nlm.nih.gov
  2. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. British Journal of Ophthalmology, 2006;90(3):262–267. pubmed.ncbi.nlm.nih.gov
  3. González-Devesa D, Suárez-Iglesias D, Diz JC, Esmerode-Iglesias A, Ayán C. Systematic review on the impact of exercise on intraocular pressure in glaucoma patients. International Ophthalmology, 2024;44(1):351. pubmed.ncbi.nlm.nih.gov
  4. Morenas-Aguilar MD, González-Hernández C, Marcos-Frutos D, et al. Acute intraocular pressure responses changes during dynamic resistance training in primary open-angle glaucoma patients and age-matched controls. Graefe's Archive for Clinical and Experimental Ophthalmology, 2025;263(10):2849–2856. pubmed.ncbi.nlm.nih.gov
  5. Morenas-Aguilar MD, Hernández CG, Marcos-Frutos D, et al. Acute intraocular pressure changes during isometric exercise in glaucoma patients: the influence of exercise and intensity. Graefe's Archive for Clinical and Experimental Ophthalmology, 2026;264(2):509–517. pubmed.ncbi.nlm.nih.gov
  6. Vieira GM, Oliveira HB, de Andrade DT, Bottaro M, Ritch R. Intraocular pressure variation during weight lifting. Archives of Ophthalmology, 2006;124(9):1251–1254. pubmed.ncbi.nlm.nih.gov
  7. Baskaran M, Raman K, Ramani KK, Roy J, Vijaya L, Badrinath SS. Intraocular pressure changes and ocular biometry during Sirsasana (headstand posture) in yoga practitioners. Ophthalmology, 2006;113(8):1327–1332. pubmed.ncbi.nlm.nih.gov
  8. Gallardo MJ, Aggarwal N, Cavanagh HD, Whitson JT. Progression of glaucoma associated with the Sirsasana (headstand) yoga posture. Advances in Therapy, 2006;23(6):921–925. pubmed.ncbi.nlm.nih.gov
  9. de Barros DS, Bazzaz S, Gheith ME, Siam GA, Moster MR. Progressive optic neuropathy in congenital glaucoma associated with the Sirsasana yoga posture. Ophthalmic Surgery, Lasers and Imaging, 2008;39(4):339–340. pubmed.ncbi.nlm.nih.gov
  10. Chetry D, Singh J, Chhetri A, Katiyar VK, Singh DS. Effect of yoga on intra-ocular pressure in patients with glaucoma: A systematic review and meta-analysis. Indian Journal of Ophthalmology, 2023;71(5):1757–1765. pubmed.ncbi.nlm.nih.gov
  11. Seo JH, Nishida T, Moghimi S, et al. Impact of Physical Activity Levels on Visual Field Progression in Individuals With Glaucoma. Journal of Glaucoma, 2025;34(7):499–506. pubmed.ncbi.nlm.nih.gov
  12. Liang Y, Yu Y, Wen X, Wang M, Lan Y, Pan X. Walking More Than 10,000 Steps Per Day May Be Associated With Increased Optic Disc Vessel Density in Patients With Primary Open Angle Glaucoma. Journal of Glaucoma, 2025;34(4):249–255. pubmed.ncbi.nlm.nih.gov
  13. Schuhmann V, Küttel J, Van Eijgen J, Gugleta K, Hanssen H. Physical activity and exercise in primary open-angle glaucoma: a scoping review. Frontiers in Physiology, 2026;17:1834649. pubmed.ncbi.nlm.nih.gov
  14. Zhou W, Fricke L, Sabel BA. Eye yoga for glaucoma: recovery of vascular dysregulation and visual field function — a randomized controlled trial. EPMA Journal, 2025;16(1):37–49. pubmed.ncbi.nlm.nih.gov
  15. Vera J, Martos-Arregui A, Alix-Fages C, Jiménez-Martínez P, García-Ramos A. Impact of Beta-Alanine, Caffeine, and Their Combination on Intraocular Pressure and Ocular Perfusion Pressure at Rest and After Resistance Training. International Journal of Sport Nutrition and Exercise Metabolism, 2025;35(3):206–214. pubmed.ncbi.nlm.nih.gov
  16. Hanyuda A, Tsuda S, Himori N, Sato K, Takahashi N, Nakazawa T. Diet, Exercise, and Lifestyle in Glaucoma: Current Evidence and Future Perspectives. Nutrients, 2025;17(21):3369. pubmed.ncbi.nlm.nih.gov
  17. Elhusseiny AM, Aref AA. Lifestyle modifications and environmental risk factors for glaucoma. Current Opinion in Ophthalmology, 2025;36(2):115–121. pubmed.ncbi.nlm.nih.gov
  18. Aggarwal S, Morya AK, Kaur R, Gurnani B, Kaur K. Role of lifestyle modifications in glaucoma: A systematic review. World Journal of Methodology, 2026;16(1):110410. pubmed.ncbi.nlm.nih.gov
  19. Reis TF, Paula JS, Furtado JM. Primary glaucomas in adults: Epidemiology and public health — A review. Clinical & Experimental Ophthalmology, 2022;50(2):128–142. pubmed.ncbi.nlm.nih.gov
  20. Fernandes AG, Berezovsky A, Watanabe SES, et al. Prevalence of ocular findings regardless of visual acuity status in older adults from the Brazilian Amazon Region. Scientific Reports, 2021;11(1):23710. pubmed.ncbi.nlm.nih.gov
  21. Jonas JB, Aung T, Bourne RR, Bron AM, Ritch R, Panda-Jonas S. Glaucoma. The Lancet, 2017;390(10108):2183–2193. pubmed.ncbi.nlm.nih.gov